Kukor, L., BERTOLI, S., CREVECOEUR, J., Bours, V., & BULK, S. (21 April 2022). What does a Genetic Counsellor do in the University Hospital of Liège ? [Poster presentation]. BeSHG/NVHG Annual Genetics Symposium 2022. |
CREVECOEUR, J., Kaminski, R., Rogister, B., Foerch, P., Vandenplas, C., Neveux, M., Mazzuferi, M., KROONEN, J., Poulet, C., MARTIN, D., SADZOT, B., RIKIR, E., Klitgaard, H., MOONEN, G., & Deprez, M. (2014). Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Neuropathology and Applied Neurobiology, 40 (2), 191-204. doi:10.1111/nan.12054 Peer Reviewed verified by ORBi |
Crèvecoeur, J. (2009). Etude du mécanisme d'activation in vitro et in vivo du facteur de transcription NF-kappaB via la phosphorylation d'IkappaBalpha sur tyrosine [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315246 |
Crèvecoeur, J., Piette, J., & Gloire, G. (2008). Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kB activation. Biochemical Pharmacology, 75 (11), 2183-2191. doi:10.1016/j.bcp.2008.03.009 Peer Reviewed verified by ORBi |